Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-51,100
Closed -$2.47M 5832
2022
Q4
$2.47M Buy
+51,100
New +$2.24M ﹤0.01% 1879
2019
Q3
Sell
-400
Closed -$17K 7810
2019
Q2
$17K Sell
400
-100
-20% -$4.25K ﹤0.01% 7144
2019
Q1
$22K Sell
500
-900
-64% -$38.6K ﹤0.01% 6912
2018
Q4
$61K Sell
1,400
-1,400
-50% -$61.7K ﹤0.01% 6073
2018
Q3
$125K Sell
2,800
-3,600
-56% -$154K ﹤0.01% 5689
2018
Q2
$256K Sell
6,400
-2,600
-29% -$102K ﹤0.01% 4801
2018
Q1
$361K Buy
9,000
+3,200
+55% +$133K ﹤0.01% 4334
2017
Q4
$249K Sell
5,800
-200,000
-97% -$9.22M ﹤0.01% 4844
2017
Q3
$10.2M Buy
205,800
+197,900
+2,505% +$9.58M 0.01% 1221
2017
Q2
$378K Sell
7,900
-2,200
-22% -$105K ﹤0.01% 4249
2017
Q1
$457K Buy
10,100
+2,000
+25% +$84.8K ﹤0.01% 3942
2016
Q4
$328K Sell
8,100
-5,700
-41% -$225K ﹤0.01% 4817
2016
Q3
$527K Buy
13,800
+13,400
+3,350% +$538K ﹤0.01% 3853
2016
Q2
$17K Sell
400
-1,300
-76% -$53.3K ﹤0.01% 6252
2016
Q1
$68K Buy
1,700
+1,300
+325% +$52.2K ﹤0.01% 5931
2015
Q4
$17K Sell
400
-600
-60% -$27.6K ﹤0.01% 6575
2015
Q3
$47K Buy
+1,000
New +$50.9K ﹤0.01% 5485

Other funds holding SNY

Citigroup's SNY Position: Q1 2026 in Review

Citigroup increased its Sanofi (SNY) stake by 220% in Q1 2026, buying an estimated $8.29M and bringing the position to 258,597 shares worth $12.5M. The position accounts for 0.01% of the portfolio, ranked #1339.

Citigroup first reported a position in SNY in Q2 2013 and has held it in 52 quarters since. The position peaked at $62.8M in Q1 2023. 738 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Citigroup held 258,597 shares of Sanofi worth $12.5M as of Q1 2026.
  • Citigroup bought 177,799 Sanofi shares in Q1 2026, an estimated $8.29M.
  • Sanofi made up 0.01% of Citigroup's portfolio in Q1 2026, its #1339 holding.
  • Citigroup first reported a position in Sanofi in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's Sanofi position peaked at $62.8M in Q1 2023.
  • 738 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.